Eric Lefkofsky is the CEO and founder of Tempus, and he is leading the way for a modern approach to dealing with cancer. Tempus is a health-tech company that offers physicians the tools they need to give their patients a personalized cancer treatment experience. By providing a genomic sequencing service that looks at molecular data and analyzes it, physicians can make data-driven, real-time decisions that can alter the life of their cancer patients. Recently, Tempus has teamed up with the University of Michigan to offer them transcriptomic and genomic sequencing along with analysis for pancreatic cancer patients being treated there. Eric recognized that Pancreatic cancer patients face some of the toughest odds, but he believes that is going to change as Tempus provides them data to access numerous targeted therapies with proven effectiveness.
While it is Eric Lefkofksy’s passion to help people who suffer including cancer, this isn’t the only way he offers help to the world. As a very active philanthropist, his wife and himself donate large sums to a variety of organizations through their charitable trust, the Lefkofsky Foundation. They support a range of charitable causes and organizations that include the Museum of Contemporary Art, Anderson Ranch Arts Center, University of Michigan Health System, Duke Medicine, Preston Robert Tisch Brain Tumor Center, Americans for Responsible Solutions, Shining Hope for Communities, AUSL (Academy for Urban School Leadership), Young Women’s Leadership Charter School, The Ounce of Prevention Fund, and many, many more.
Eric Lefkofksy graduated from Southfield-Lathrup High School in 1987 and went on to attend the University of Michigan where he graduated with honors in 1991. After that, he decided to continue on and received his Juris Doctor, in 1993, from the University of Michigan Law School. As a firm believer in the power of education, Eric is happy to be a partner of many different Universities who is studying and treating cancer. On his Facebook page, he proudly shares information about these partnerships and highlights some of the charitable causes he supports.